BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
0.8080
+0.0152 (1.92%)
At close: Jul 31, 2026, 4:00 PM EDT
0.8100
+0.0020 (0.25%)
After-hours: Jul 31, 2026, 7:34 PM EDT
BioXcel Therapeutics Market Cap
BioXcel Therapeutics has a market cap or net worth of $24.95 million as of July 31, 2026. Its market cap has increased by 186.77% in one year.
Market Cap
24.95M
Enterprise Value
108.06M
1-Year Change
186.77%
Ranking
Category
Stock Price
$0.81
ChartMarket Cap Chart
Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $167.60M to $24.95M, a decrease of -85.11%. That is a compound annual growth rate of -20.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 24.90M | -28.86% |
| Dec 31, 2025 | 35.00M | 118.75% |
| Dec 31, 2024 | 16.00M | -81.48% |
| Dec 29, 2023 | 86.40M | -85.65% |
| Dec 30, 2022 | 601.90M | 5.82% |
| Dec 31, 2021 | 568.80M | -49.48% |
| Dec 31, 2020 | 1.13B | 327.25% |
| Dec 31, 2019 | 263.50M | 336.26% |
| Dec 31, 2018 | 60.40M | -63.96% |
| Mar 8, 2018 | 167.60M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InterCure | 56.18M |
| Citius Oncology | 55.07M |
| SCYNEXIS | 48.06M |
| China Pharma Holdings | 44.98M |
| Incannex Healthcare | 35.18M |
| Rockwell Medical | 28.38M |
| Optimi Health | 27.55M |
| Aytu BioPharma | 23.94M |